20Slash20 Inc., the company behind The Eye Drink, has announced its participation in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for Sept. 9–10, 2026, in New York City. CEO Dr. Roger Wu will deliver an investor presentation at 9:35 a.m. ET on Sept. 9 at The Westin New York Grand Central, followed by one-on-one meetings with investors. The conference aims to bring together growth companies, investors, and industry professionals across life sciences and other emerging sectors, providing a platform for 20Slash20 to showcase its innovative approach to eye health.
The Eye Drink is positioned as the world’s first ready-to-drink functional beverage formulated with science-backed ingredients to support eye health for individuals who spend extended periods on phones and computers. With the increasing prevalence of digital eye strain, the product addresses a growing health concern. According to the company, The Eye Drink offers a convenient and tasty solution to protect eyes from screen-induced problems, catering to the modern, screen-centric lifestyle.
The significance of this announcement extends beyond the company's marketing efforts. It underscores a broader trend in the beverage industry toward functional products that target specific health issues. As consumers become more health-conscious and technology-dependent, the demand for products like The Eye Drink is likely to rise. This conference presentation provides 20Slash20 with an opportunity to attract potential investors and partners, which could accelerate its growth and market penetration.
Investor attention on such companies is intensifying as the functional beverage market expands. According to industry reports, the global functional drinks market is projected to grow significantly in the coming years, driven by innovations in health-focused formulations. 20Slash20’s entry into this space with a niche product for eye health could position it well to capture a segment of this market.
The conference also highlights the increasing intersection of life sciences and consumer products. By presenting at a conference that focuses on disruptive growth and life sciences, 20Slash20 aligns itself with cutting-edge developments in health and wellness. This could enhance its credibility among investors who are looking for companies that combine scientific rigor with consumer appeal.
For more information about the conference or to view the full press release, interested parties can visit https://ibn.fm/tm2lT. Details about 20Slash20 and its products are available on its website. InvestorWire, a specialized communications platform, syndicated this press release, and more information about InvestorWire can be found at https://www.InvestorWire.com.
